Drug class
Capillary haemostatic agent; quinone semicarbazone derivative
Mechanism of action
Proposed to reduce capillary permeability and fragility and support local haemostasis. The precise molecular mechanism and clinical effectiveness are not well established by modern high-quality evidence.
General use cases
- Used in some countries for prevention or treatment of capillary bleeding and haemorrhage associated with increased capillary permeability; efficacy and authorisation vary by jurisdiction and indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
